Table 2 Oral anticoagulant and antiplatelet therapy use at the time of hospital discharge and at the time of CT scan
From: Hypo-attenuated leaflet thickening in surgically-implanted mitral bioprosthesis
Medications | At discharge (N = 53) | At CT (N = 53) |
|---|---|---|
SAPT | 3 (5.7) | 13 (24.5) |
DAPT | 0 (0.0) | 2 (3.8) |
SAPT + warfarin | 39 (73.6) | 14 (26.4) |
SAPT + DOAC | 0 (0.0) | 0 (0.0) |
Warfarin | 11 (20.8) | 23 (43.4) |
DOAC | 0 (0.0) | 1 (1.9) |
Unknown | 0 (0.0) | 0 (0.0) |